Plasma levels of tumor necrosis factor-alpha in patients with visceral leishmaniasis (Kala-Azar). Association with activity of the disease and clinical remisson following antimonial therapy

Authors

  • Reinaldo Salomão Escola Paulista de Medicina; Division of Infectious Diseases
  • Adauto Castelo Filho Escola Paulista de Medicina; Division of Infectious Diseases
  • Iara Marques de Medeiros Universidade Federal do Rio Grande do Norte; Division of Infectious Diseases
  • Miguel Angel Sicolo Universidade Federal do Rio Grande do Norte; Division of Infectious Diseases

Keywords:

Cytokines, TNF-alpha, Visceral Leishmaniasis (Kala-Azar)

Abstract

Evaluation of TNF-alpha in patients with Kala-azar has drawn increasing interest due to its regulatory role on the immune system, in addition to its cachetizing activity. The objective of this study was to examine the association between plasma levels of TNF-alpha, measured by immunore-activity (ELISA) and bioactivity (cytotoxicity assay with L-929 cells), and clinical manifestations of visceral leishmaniasis. Plasma samples from 19 patients with Kala-azar were obtained before, during and at the end of antimonial therapy. TNF-alpha determinations was done by using the cytotoxicity assay (all patients) and the enzyme-linked immunoassay (ELISA - 14 patients). A discrepancy between results obtained by ELISA and cytotoxicity assay was observed. Levels of circulating TNF-alpha, assessed by ELISA, were higher in patients than in healthy controls, and declined significantly with improvement in clinical and laboratory parameters. Plasma levels before treatment were 124.7 ± 93.3 pg/ml (mean ± SD) and were higher than at the end of therapy 13.9 ± 25.1 pg/ml (mean ± SD) (p = 0.001). In contrast, plasma levels of TNF-alpha evaluated by cytotoxicity assay did not follow a predicted course during follow-up. Lysis, in this case, might be not totally attributed to TNF-alpha. The discrepancy might be attributed to the presence of factor(s) known to influence the release and activity of TNF-alpha.

Downloads

Download data is not yet available.

Downloads

Published

1996-04-01

Issue

Section

Immunology

How to Cite

Salomão, R., Castelo Filho, A., Medeiros, I. M. de, & Sicolo, M. A. (1996). Plasma levels of tumor necrosis factor-alpha in patients with visceral leishmaniasis (Kala-Azar). Association with activity of the disease and clinical remisson following antimonial therapy . Revista Do Instituto De Medicina Tropical De São Paulo, 38(2), 113-118. https://revistas.usp.br/rimtsp/article/view/29348